Hongmei Mo

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection

Tuofu Zhu, Hongmei Mo, Ning Wang et al. · Science · 1993 · 1.2K citations

Life Sciences, Genetics, Infectious Diseases +17

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 850 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

Akhteruzzaman Molla, Marina Korneyeva, Qing Gao et al. · Nature Medicine · 1996 · 768 citations

Life Sciences, Genetics, Molecular Biology +14

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

Eric Lawitz, Fred Poordad, Phillip S. Pang et al. · The Lancet · 2013 · 549 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15